Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels.  Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.

Qiming Venture Partners

Morningside Venture Investments

Morningside Ventures

Illumina Ventures

Samsara BioCapital

Sherpa Venture Capital

Alamar Biosciences, Inc.

Exciting news from Alamar Biosciences! We've raised $128 million in an oversubscribed Series C financing round led by Sands Capital, bringing our total funding to nearly $250 million. This funding will accelerate the commercialization of our NULISA™ Platform and ARGO™ HT System and continues our mission of powering precision #proteomics to enable the earliest detection of disease. https://ow.ly/4iky50QI0hU

 #NULISA #Funding

Happy National Engineer week! This week, we proudly recognize and celebrate the incredible work of engineers around the world, including our exceptional team at Alamar Biosciences.

During National Engineers Week, Alamar Biosciences pays tribute to the remarkable engineers who bridge the gap between imagination and reality. From designing cutting-edge biotech solutions to pushing the boundaries of innovation, we salute the problem solvers and visionaries who make a difference. 🚀🔬💡 

#EngineersWeek #EngineeringExcellence

🔬 Explore the depths of autoimmune research with the NULISAseq™ Inflammation Panel 250! Apply by March 31, 2024, for a chance to win one of three grant awards from our Autoimmune Grant Program. Detect key cytokine markers with unparalleled sensitivity. Don't miss out on this opportunity to advance your protein biomarker research! 
Learn more: https://lnkd.in/gVmDxdzg
#AutoimmuneResearch #GrantProgram #Cytokines #Innovation #immunoassay

Develops technologies for early cancer detection

Grail

Specializes in non-invasive cancer diagnostics

Guardant Health

Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company has created a highly sensitive proteomics platform capable of profiling thousands of proteins simultaneously in a small volume of plasma.

Senior Director, Service Support

Global Manager, Field Service

Manager,  Field Service

Staff Field Service Engineer

Sr Field Service Engineer

Service and Support Manager

Technical Service and Support Manager

Regional Territory Specialist (US)

Biotechnology Service and Support Professional

Matt Stanley

Founder, COO

COO (ACD division)

Founder & COO

Director of Engineering

Founder, CTO

Founder, COO at Alamar Biosciences, Inc.

Steve Chen

Chief Financial Officer & Chief Business Officer

Managing Member

General Counsel, Vice President

Attorney

Chief Financial Officer & Chief Business Officer at Alamar Biosciences, Inc.

Tod White

Senior Director, Software Engineering

Vice President of Software at Berkeley Lights/PhenomeX

Director of Software Algorithms

Principal Software Design Engineer

Sr. Director of Software Development

Director of Research

Chief Software Architect

Vice President of Software

John Tenney

European Sales Director

Co-Founder

Business Consultant

CEO - Cofounder

Board Member

Consultant

VP/GM EMEA

European Business Development Manager

Senior Account Manager

Genomics Sales Specialist

Territory manager Northern UK

Director - co founder

Believer in science driven public health policy

Michael Evans

Sr Director, Assay Development and Services

Sr Director, Product Development

R&D director

R&D group lead

Senior Scientist

Sr Director, Assay Development/Product Development/Services

Bingqing Zhang

Senior Director of Bioinformatics

Director of Bioinformatics

Research Leader

Principal Scientist II

Principal Scientist I

Bioinformatics Scientist

Postdoctoral Fellow, Fuel Synthesis

Bioinformatics Software Engineer

Dwight Kuo

Director of NPI and Manufacturing Engineering

Director of NPI and Hardware Engineering

Technical Program Manager

Principal Manufacturing Engineer

Sr. Manager of Manufacturing Engineering

Sr. Director of Manufacturing Engineering and Operation

Principal R&D Engineer

Hong L.

Director

Associate Director

Sr. Manager

Senior Staff Scientist

Staff Scientist

Scientist

Postdoctoral fellow

Director at Alamar Biosciences, Inc.

Xiaolei Qiu

Regional Sales Director

Sr. Regional Business Manager, New England & Mid-Atlantic

Regional Business Manager, New England & Mid-Atlantic

Sr. Field Application Scientist

Field Application Scientist

Senior Process Engineer

Senior Associate Scientist- Nanomedicine Development and Manufacturing

Engineer

Associate Engineer

Research Associate

Co-op

Co-op intern

Max Mahoney

Co-founder, VP of Technology

Co-founder, Director of R&D

Group leader, Antibody Engineering

Postdoctoral Research Fellow

Faculty Research Assistant

Graduate Research Assistant

Co-founder and VP, Technology at Alamar Biosciences

Yiyuan Yin

Sr. Director, Commercial Marketing

Sr. Director, Global Brand & Marketing Communications

Director, Global Marketing Communications

Director, Corporate Communications

Manager, Product Communications

Sr. Manager, Marketing Communications

Owner

Marketing Specialist / Graphic Designer

April Falcone

Director West

Director-Commercial

Director Business Development & Commercialization

Director Business Development Translational Biomarkers and Companion Diagnostics

Business Development Manager

Pharmaceutical Key Account Manager

Biotechnology Business Development and Commercialization

Brad Nawa

Founder, Chairman & CEO,

Co-Founder & Chairman of BOD

President, Advanced Cell Diagnostics

Founder, President & CEO

Founder & VP

Founder, Chairman & CEO, at Alamar Biosciences

Yuling Luo

Head of Human Resources

Head of Global Human Resources

Merinda Do

Senior Director Manufacturing

Director Of Manufacturing

Associate Director of Manufacturing

Senior Manager of Manufacturing

James Pang

Director of R&D

Group Lead

Senior Scientist II

Graduate Student Researcher

Wei Feng

Senior Director of Application Support

Senior Director of Customer Experience

Director of Product Applications

Principal Product Application Scientist

Senior Field Application Scientist, Single Cell Biology

Director of Clinical Genomics and Translational Technologies

Associate Director of Genome Technologies

Senior Manager, Molecular Phenotyping

Douglas Hinerfeld

Senior Director, Human Resources

Vice President, People Team

Head Of Human Resources

Associate Director, Human Resources

Senior Manager, Human Resources

Human Resources Manager

Operations Coordinator

Senior Human Resources Leader

Alyssa McConnell

Alamar Biosciences

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

news impact assignment basic	general	Mar 1, 2024 10:50 PM	93efb220
public peers	general
news daily refresh	general	Sep 2, 2024 9:30 AM	afa1fa50
news processing daily refresh	general	Sep 2, 2024 1:59 PM	fe0b233a
news impact assignment daily	general	Sep 2, 2024 11:07 PM	60e6fea3
news processing basic	general	Mar 1, 2024 10:50 PM	c1e2534a
company summary	general	Aug 30, 2024 5:11 PM	f1b81577
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 1, 2024 10:50 PM	4f1229f5
translate crunchbase fundingrounds	general
peers	general
news basic	general	Mar 1, 2024 10:50 PM	e075b796
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ALAMARBIO

Alamar Biosciences